Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
[Systematic review of studies assessing the cost of adverse drug reactions].

Gaceta sanitaria

Vallano Ferraz A, Agustí Escasany A, Pedrós Xolvi C, Arnau de Bolós JM.
PMID: 22152925
Gac Sanit. 2012 May-Jun;26(3):277-83. doi: 10.1016/j.gaceta.2011.09.014. Epub 2011 Dec 06.

OBJECTIVE: Adverse drug reactions (ADRs) are an important healthcare problem. The objective of this study was to review published articles analyzing the cost of ADRs in any healthcare setting.METHOD: We conducted a search of articles published on the cost...

Cite
Vallano Ferraz A, Agustí Escasany A, Pedrós Xolvi C, et al. Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos. [Systematic review of studies assessing the cost of adverse drug reactions]. Gac Sanit. 2011;26(3):277-83doi: 10.1016/j.gaceta.2011.09.014.
Vallano Ferraz, A., Agustí Escasany, A., Pedrós Xolvi, C., & Arnau de Bolós, J. M. (2012). Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos. [Systematic review of studies assessing the cost of adverse drug reactions]. Gaceta sanitaria, 26(3), 277-83. https://doi.org/10.1016/j.gaceta.2011.09.014
Vallano Ferraz, Antonio, et al. "Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos." [Systematic review of studies assessing the cost of adverse drug reactions]. Gaceta sanitaria vol. 26,3 (2012): 277-83. doi: https://doi.org/10.1016/j.gaceta.2011.09.014
Vallano Ferraz A, Agustí Escasany A, Pedrós Xolvi C, Arnau de Bolós JM. Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos. [Systematic review of studies assessing the cost of adverse drug reactions]. Gac Sanit. 2012 May-Jun;26(3):277-83. doi: 10.1016/j.gaceta.2011.09.014. Epub 2011 Dec 06. Spanish. PMID: 22152925.
Copy Download .nbib Format: NLM
[Preventive work can reduce drug side effects].

Lakartidningen

Hallberg P, Collin S, Wadelius M.
PMID: 28718862
Lakartidningen. 2017 Jul 14;114.

No abstract available.

Cite
Hallberg P, Collin S, Wadelius M. Preventivt arbete kan minska läkemedelsbiverkningar. [Preventive work can reduce drug side effects]. Lakartidningen. 2017;114
Hallberg, P., Collin, S., & Wadelius, M. (2017). Preventivt arbete kan minska läkemedelsbiverkningar. [Preventive work can reduce drug side effects]. Lakartidningen, 114.
Hallberg, Pär, et al. "Preventivt arbete kan minska läkemedelsbiverkningar." [Preventive work can reduce drug side effects]. Lakartidningen vol. 114 (2017).
Hallberg P, Collin S, Wadelius M. Preventivt arbete kan minska läkemedelsbiverkningar. [Preventive work can reduce drug side effects]. Lakartidningen. 2017 Jul 14;114. Swedish. PMID: 28718862.
Copy Download .nbib Format: NLM
Rare disease prevention and treatment: the need for a level playing field.

Pharmacogenomics

Hughes DA, Plumpton CO.
PMID: 29327657
Pharmacogenomics. 2018 Feb;19(3):243-247. doi: 10.2217/pgs-2017-0300. Epub 2018 Jan 12.

Pharmacogenetic tests are being used increasingly to prevent rare and potentially life-threatening adverse drug reactions. For many tests, however, cost-effectiveness is hard to demonstrate, and with the exception of a few cases, widespread implementation remains a distant prospect. Many...

Cite
Hughes DA, Plumpton CO. Rare disease prevention and treatment: the need for a level playing field. Pharmacogenomics. 2018;19(3):243-247doi: 10.2217/pgs-2017-0300.
Hughes, D. A., & Plumpton, C. O. (2018). Rare disease prevention and treatment: the need for a level playing field. Pharmacogenomics, 19(3), 243-247. https://doi.org/10.2217/pgs-2017-0300
Hughes, Dyfrig A, and Plumpton, Catrin O. "Rare disease prevention and treatment: the need for a level playing field." Pharmacogenomics vol. 19,3 (2018): 243-247. doi: https://doi.org/10.2217/pgs-2017-0300
Hughes DA, Plumpton CO. Rare disease prevention and treatment: the need for a level playing field. Pharmacogenomics. 2018 Feb;19(3):243-247. doi: 10.2217/pgs-2017-0300. Epub 2018 Jan 12. PMID: 29327657.
Copy Download .nbib Format: NLM
The economic burden of preventable adverse drug reactions: a systematic review of observational studies.

Expert opinion on drug safety

Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, Ingrasciotta Y, Salvo F, Spina E, Trifirò G.
PMID: 29952667
Expert Opin Drug Saf. 2018 Jul;17(7):681-695. doi: 10.1080/14740338.2018.1491547. Epub 2018 Jul 03.

INTRODUCTION: Adverse drug reactions (ADRs) are an important cause of morbidity and mortality worldwide. They are associated with healthcare costs due to hospital admissions or prolonged length of stay, as well as additional interventions. The aim of this study...

Cite
Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681-695doi: 10.1080/14740338.2018.1491547.
Formica, D., Sultana, J., Cutroneo, P. M., Lucchesi, S., Angelica, R., Crisafulli, S., Ingrasciotta, Y., Salvo, F., Spina, E., & Trifirò, G. (2018). The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert opinion on drug safety, 17(7), 681-695. https://doi.org/10.1080/14740338.2018.1491547
Formica, D, et al. "The economic burden of preventable adverse drug reactions: a systematic review of observational studies." Expert opinion on drug safety vol. 17,7 (2018): 681-695. doi: https://doi.org/10.1080/14740338.2018.1491547
Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, Ingrasciotta Y, Salvo F, Spina E, Trifirò G. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018 Jul;17(7):681-695. doi: 10.1080/14740338.2018.1491547. Epub 2018 Jul 03. PMID: 29952667.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries